findmyKOL

Xihui Lin, MD

Basic profile

Wayne State University

ORCIDNPI
RegionDetroit, MI · MidwestSpecialtyOphthalmologyFocusOphthalmology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Xihui Lin is an Ophthalmology physician affiliated with Wayne State University. OpenAlex indexes 63 publications with 268 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
63publications

Distinct works indexed by OpenAlex, matched via ORCID.

268citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    48.4%
    Corticosteroid11.2%
    Prednisolone Acetate100%
    Part D35 patients
    alpha-Adrenergic Agonist9.1%
    Brimonidine Tartrate100%
    Part D31 patients

    + 4 more classes in this area

  • Cancer & immunology

    33%
    Vascular Endothelial Growth Factor Inhibitor30.7%
    Aflibercept88%Bevacizumab12%
    Part B, office-administered38 patients
    Folate Analog Metabolic Inhibitor2.2%
    Methotrexate100%
    Part D<11 patients
  • Musculoskeletal

    7.1%
    Nonsteroidal Anti-inflammatory Drug6%
    Diclofenac Sodium100%
    Part D28 patients
    Cyclooxygenase Inhibitor1.1%
    Ketorolac Tromethamine100%
    Part D<11 patients
Where care is delivered (Part B)1.1% facility · 98.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”